Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
Publication
, Journal Article
Thomas, LE; Bonow, RO; Pencina, MJ
Published in: JAMA Cardiol
September 1, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
September 1, 2020
Volume
5
Issue
9
Start / End Page
988 / 990
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Coronavirus Infections
- Coronavirus
- COVID-19
- Betacoronavirus
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin Receptor Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
Thomas, L. E., Bonow, R. O., & Pencina, M. J. (2020). Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, 5(9), 988–990. https://doi.org/10.1001/jamacardio.2020.1874
Thomas, Laine E., Robert O. Bonow, and Michael J. Pencina. “Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).” JAMA Cardiol 5, no. 9 (September 1, 2020): 988–90. https://doi.org/10.1001/jamacardio.2020.1874.
Thomas LE, Bonow RO, Pencina MJ. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):988–90.
Thomas, Laine E., et al. “Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).” JAMA Cardiol, vol. 5, no. 9, Sept. 2020, pp. 988–90. Pubmed, doi:10.1001/jamacardio.2020.1874.
Thomas LE, Bonow RO, Pencina MJ. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):988–990.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
September 1, 2020
Volume
5
Issue
9
Start / End Page
988 / 990
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Coronavirus Infections
- Coronavirus
- COVID-19
- Betacoronavirus
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin Receptor Antagonists